Literature DB >> 12574085

Atrial fibrillation in hypertension: predictors and outcome.

Paolo Verdecchia1, GianPaolo Reboldi, Roberto Gattobigio, Maurizio Bentivoglio, Claudia Borgioni, Fabio Angeli, Erberto Carluccio, Maria Grazia Sardone, Carlo Porcellati.   

Abstract

Incidence, determinants, and outcome of atrial fibrillation in hypertensive subjects are incompletely known. We followed for up to 16 years 2482 initially untreated subjects with essential hypertension. At entry, all subjects were in sinus rhythm. Subjects with valvular heart disease, coronary artery disease, preexcitation syndrome, thyroid disorders, or lung disease were excluded. During follow-up, a first episode of atrial fibrillation occurred in 61 subjects at a rate of 0.46 per 100 person-years. At entry, subjects with future atrial fibrillation differed (all P<0.05) from those without by age (59 versus 51 years), office, and 24-hour systolic blood pressure (165 and 144 versus 157 and 137 mm Hg, respectively), left ventricular mass (58 versus 49 g/height[m](2.7)), and left atrial diameter (3.89 versus 3.56 cm). Age and left ventricular mass (both P<0.001) were the sole independent predictors of atrial fibrillation. For every 1 standard deviation increase in left ventricular mass, the risk of atrial fibrillation was increased 1.20 times (95% CI, 1.07 to 1.34). Atrial fibrillation became chronic in 33% of subjects. Age, left ventricular mass, and left atrial diameter (all P<0.01) were independent predictors of chronic atrial fibrillation. Ischemic stroke occurred at a rate of 2.7% and 4.6% per year, respectively, among subjects with paroxysmal and chronic atrial fibrillation. These data indicate that in hypertensive subjects with sinus rhythm and no other major predisposing conditions, risk of atrial fibrillation increases with age and left ventricular mass. Increased left atrial size predisposes to chronicization of atrial fibrillation.

Entities:  

Mesh:

Year:  2003        PMID: 12574085     DOI: 10.1161/01.hyp.0000052830.02773.e4

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  61 in total

Review 1.  Echocardiographic quantification of left ventricular mass: prognostic implications.

Authors:  Rajiv S Swamy; Roberto M Lang
Journal:  Curr Cardiol Rep       Date:  2010-05       Impact factor: 2.931

Review 2.  Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

Authors:  Teresa M Seccia; Brasilina Caroccia; Gail K Adler; Giuseppe Maiolino; Maurizio Cesari; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-04       Impact factor: 10.190

3.  Atrial extrasystoles after exercise predict atrial fibrillation in patients with left ventricular hypertrophy.

Authors:  R J Folkeringa; J Hartgers; R G Tieleman; A P Gorgels; W R M Dassen; H J G M Crijns
Journal:  Heart       Date:  2006-04       Impact factor: 5.994

4.  Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).

Authors:  Jonathan Chrispin; Aditya Jain; Elsayed Z Soliman; Eliseo Guallar; Alvaro Alonso; Susan R Heckbert; David A Bluemke; João A C Lima; Saman Nazarian
Journal:  J Am Coll Cardiol       Date:  2014-03-19       Impact factor: 24.094

Review 5.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

6.  Is there an association between the prevalence of atrial fibrillation and severity and control of hypertension? The REasons for Geographic And Racial Differences in Stroke study.

Authors:  Hemal Bhatt; Christopher M Gamboa; Monika M Safford; Elsayad Z Soliman; Stephen P Glasser
Journal:  J Am Soc Hypertens       Date:  2016-05-30

7.  Usefulness of pharmacologic conversion of atrial fibrillation during dofetilide loading without the need for electrical cardioversion to predict durable response to therapy.

Authors:  Rohit Malhotra; Kenneth C Bilchick; John P DiMarco
Journal:  Am J Cardiol       Date:  2013-11-09       Impact factor: 2.778

8.  Possible beneficial effect of olmesartan medoxomil on left atrial function in patients with hypertension : noninvasive assessment by acoustic quantification.

Authors:  Hui-Ping Gong; Wei Zhang; Li Li; Hong-Wei Tan; Zhi-Yong Ma; Xue-Zhen Zhong; Zhi-Hao Wang; Tao Song; Yun Zhang; Ming Zhong
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 9.  Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation.

Authors:  Gerald V Naccarelli; Frank Peacock
Journal:  Vasc Health Risk Manag       Date:  2009-09-18

Review 10.  A combined role of calcium channel blockers and angiotensin receptor blockers in stroke prevention.

Authors:  Ji-Guang Wang
Journal:  Vasc Health Risk Manag       Date:  2009-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.